Showing results (151-160 of 183) with videos related to
Sort By:
Pageof 19
Chemmedchem|February 27, 2016
In Vivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant AgentsElvira Bruno, Maria R Buemi, Laura De Luca, et al.RSC Medicinal Chemistry|June 25, 2025
Structure-based design and evaluation of tyrosinase inhibitors targeting both human and mushroom isozymesSalvatore Mirabile, Giovanna Pitasi, Sonia Floris, et al.Clinical Transplantation|May 13, 2017
An objective definition for clinical suspicion of T-cell-mediated rejection after liver transplantationManuel Rodríguez-Perálvarez, Laura De Luca, Gonzalo Crespo, et al.European Journal of Medicinal Chemistry|February 3, 2022
Cinnamic acid derivatives linked to arylpiperazines as novel potent inhibitors of tyrosinase activity and melanin synthesisRomeo Romagnoli, Paola Oliva, Filippo Prencipe, et al.Bioorganic Chemistry|October 21, 2021
Exploration of the 2,3-dihydroisoindole pharmacophore for inhibition of the influenza virus PA endonucleaseDominga Rogolino, Lieve Naesens, Jennifer Bartoli, et al.Journal of Medicinal Chemistry|April 29, 2005
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RTMaria Letizia Barreca, Angela Rao, Laura De Luca, et al.Bioorganic & Medicinal Chemistry|January 14, 2014
Synthesis, modelling and biological characterization of 3-substituted-1H-indoles as ligands of GluN2B-containing N-methyl-d-aspartate receptorsRosaria Gitto, Laura De Luca, Stefania Ferro, et al.Bioorganic & Medicinal Chemistry|July 1, 2008
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitorsAnna-Maria Monforte, Angela Rao, Patrizia Logoteta, et al.Journal of Medicinal Chemistry|December 5, 2008
Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domainMuriel Billamboz, Fabrice Bailly, Maria Letizia Barreca, et al.Journal of Medicinal Chemistry|April 11, 2018
Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine FragmentsStefania Ferro, Batel Deri, Maria Paola Germanò, et al.Pageof 19